About Congenital cataract-hypertrophic cardiomyopathy-mitochondrial myopathy syndrome
Congenital cataract-hypertrophic cardiomyopathy-mitochondrial myopathy syndrome is a rare disease catalogued by Orphanet (ORPHA:1369). It is associated with the TKFC, SLC25A4, AGK genes. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Congenital cataract-hypertrophic cardiomyopathy-mitochondrial myopathy syndrome trials.
Search ClinicalTrials.gov for "Congenital cataract-hypertrophic cardiomyopathy-mitochondrial myopathy syndrome" or filter by Orphanet code ORPHA:1369 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Congenital cataract-hypertrophic cardiomyopathy-mitochondrial myopathy syndrome trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Congenital cataract-hypertrophic cardiomyopathy-mitochondrial myopathy syndrome. Updated daily.